Pharmacyclics is committed to the development and commercialization of novel therapies intended to improve the quality and duration of life and to resolve serious unmet medical needs for cancer patients. Pharmacyclics is a wholly-owned subsidiary of AbbVie (NYSE:ABBV), a global, research-based biopharmaceutical company. Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products and a pipeline containing multiple promising new molecules that are being studied in more than 200 clinical trials for over 20 different types of cancer. More than 1,200 Pharmacyclics and AbbVie research scientists, clinicians, marketing, operations and corporate professionals work in the San Francisco Bay Area. They combine their expertise in immuno-oncology, stem cells, and cell-signaling with their knowledge of bispecific antibodies, antibody-drug conjugates (ADCs), and covalent-inhibitor technologies to discover and develop novel cancer treatments. Together, we are striving to outsmart cancer. Review our LinkedIn community guidelines at http://bit.ly/AbbVieSocialGuidelines.
View Top Employees from Pharmacyclics, an AbbVie Company| Website | http://www.pharmacyclics.com |
| Revenue | $729 million |
| Employees | 746 (656 on RocketReach) |
| Founded | 1991 |
| Address | 999 East Arques Avenue, Sunnyvale, California 94085, US |
| Phone | (408) 215-3000 |
| Fax | (408) 215-3689 |
| Technologies |
JavaScript,
HTML,
Font Awesome
+120 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Healthcare |
| Keywords | Pharmaceutical Development, Cancer Treatment, Biopharmaceuticals, Cancer Therapeutics, Oncology, Cell Therapies, Drug Development And Manufacturing, Biotechnology, Cancer Research |
| Competitors | Acadia Pharmaceuticals Inc., Clovis Oncology, Exelixis, Kite Pharma, Relypsa |
| SIC | SIC Code 283 Companies, SIC Code 809 Companies, SIC Code 2833 Companies, SIC Code 80 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 62 Companies, NAICS Code 6219 Companies, NAICS Code 621 Companies, NAICS Code 62199 Companies |
Looking for a particular Pharmacyclics, an AbbVie Company employee's phone or email?
Pharmacyclics, an AbbVie Company Questions
The Pharmacyclics, an AbbVie Company annual revenue was $729 million in 2024.
Maky Zanganeh is the COO of Pharmacyclics, an AbbVie Company.
656 people are employed at Pharmacyclics, an AbbVie Company.
Pharmacyclics, an AbbVie Company is based in Sunnyvale, California.
The NAICS codes for Pharmacyclics, an AbbVie Company are [62, 6219, 621, 62199].
The SIC codes for Pharmacyclics, an AbbVie Company are [283, 809, 2833, 80, 28].
Top Pharmacyclics, an AbbVie Company Employees
-
ViewMaky Zanganeh
Chief Operating Officer at Pharmacyclics, an AbbVie Company
Sunnyvale, California, United States13 -
44
-
35+
-
View
Julie Astanov
Associate Director, Global Regulatory Strategy at Pharmacyclics, an AbbVie Company
California, United States41 -
View
Kate Corpus
Director, Marketing Operations - Imbruvica at Pharmacyclics, an AbbVie Company
San Carlos, CA, US32 -
54
Related Companies
